PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Anthem BCBSMedicaid · Coverage · Provider Bulletin · VA · Oncology, Ophthalmology, Dermatology +5 moreHigh impact

[Virginia] Clinical Criteria updates

Act
by Nov 20, 2026
Effective date
Nov 20, 2026
Identified
Oct 16, 2026

Summary

HealthKeepers, Inc. (Anthem HealthKeepers Plus Medicaid) is revising 24 clinical criteria for medical drug benefits, affecting coverage requirements for oncology drugs, immunology agents, ophthalmology implants, and specialty pharmaceuticals. Twenty-two existing criteria are being revised (including Opdivo, Yervoy, Tecentriq, and others) and four new criteria are being added (Hepcludex, Decnupaz, Lumvoa, Trutakna). All changes take effect November 20, 2026.

Get alerts when payers change rules like this one

We check Anthem BCBS and other payers every day and email you when a change matches your specialty and state.

Get Anthem BCBS alertsPolicy Monitoring is free. No card required.

What to do

by Nov 20, 2026 · 3 steps
01Billing team must obtain and review the revised clinical criteria for all 26 affected drugs (24 revisions + 4 new criteria) from HealthKeepers' Clinical Criteria page to understand updated medical necessity requirements for medical drug benefit coverage.
02Update internal authorization and coverage templates to reflect revised criteria for: Ocrevus (CC-0011), Dupixent (CC-0029), Intravitreal Corticosteroid Implants (CC-0031), Botulinum Toxin (CC-0032), Monoclonal Antibodies to Interleukin-5 (CC-0043), Krystexxa (CC-0057), Palynziq (CC-0077), Abraxane (CC-0099), Xofigo (CC-0112), Yervoy (CC-0119), Gazyva (CC-0121), Opdivo (CC-0125), Tecentriq/Atezolizumab (CC-0128), Imfinzi (CC-0130), Yescarta (CC-0151), Enhertu (CC-0158), Durysta (CC-0163), Xipere (CC-0218), Qalsody (CC-0237), Vyjuvek (CC-0243), iDose TR (CC-0258), Tryngolza (CC-0276), Datroway (CC-0279), and Opdivo Qvantig (CC-0281), plus implement new criteria for Hepcludex (CC-0303), Decnupaz (CC-0304), Lumvoa (CC-0305), and Trutakna (CC-0306).
03Note: Clinical criteria apply only to medical drug benefits, not pharmacy services; separate authorization rules will be communicated separately.
If missed: Failure to implement updated criteria may result in claim denials or processing delays for affected medications.

Original notice

[Virginia] Clinical Criteria updates
providernews.anthem.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account